Independent European studies presented at CTAD 2025 and ADPD2026 confirmed that the HISCL p-Tau217 RUO* and the HISCL Aß42/40 ratio are highly ...

Hamburg, Germany, 14 April 2026 – Sysmex has officially opened its new office campus in Hamburg-Alsterdorf, completing the relocation of its EMEA headquarters from Norderstedt to the city. Around 780 ...

PARIS, April 01, 2025 (GLOBE NEWSWIRE) -- Sysmex’s PA-100 AST System is redefining standard of care for diagnosing and treating urinary tract infections (UTIs). By combining cutting-edge nanofluidic ...

Norderstedt, Germany, 2 April 2024 – Sysmex Europe SE announced today the establishment of a new branch office, Sysmex Nordic ApS, branch in Finland. With this decision, Sysmex aims to enhance its ...

Article ‘Count’ and ‘Share’ for Sysmex Europe GmbH based on listed parameters only. The articles listed below published by authors from Sysmex Europe GmbH, organized by journal and article, represent ...

Fujirebio Holdings, Inc. (President CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement to expand their Contract Development ...

KOBE, Japan, March 5 /PRNewswire/ -- Sysmex Corporation (6869: Tokyo Stock Exchange), a leading medical diagnostics instrument manufacturer and laboratory information systems developer, today ...

Independent European studies presented at CTAD 2025 and ADPD2026 confirmed that the HISCL™ p-Tau217 RUO* and the HISCL™ Aβ42/40 ratio are highly accurate for early identification of Aβ pathology. By ...

Sysmex Europe SE has announced the availability of the HISCL™ automated immunoassay system for Alzheimer's blood biomarker testing, offering a fast, fully automated and non-invasive alternative to ...